Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Consumer Cyclical · Travel Services

Royal Caribbean Group logoRoyal Caribbean Group

RCL · a US exchange · USD · Market cap $90.9B · 107,950 employees

Royal Caribbean Cruises Ltd.

FAIL · Does not pass the screen
303.15 USD

Price as of 19 Nov 2026Daily close, not a live quote

Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price303.15 USD at the 19 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 19 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.52)
  • Last reviewed19 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $338.01 to $563.36, base estimate $404.34 (screen dated 2026-11-19).

Current read
Markup ?
Undervalued · screened 2026-11-19
  • Trend Markup
  • Insiders insiders sold, $62,109,253, latest filing 2026-11-11
  • Positioning political buying, disclosed 2026-10-13
  • Options put/call open interest 0.52, read 2026-11-19
  • Ethical does not pass the values gate
Price303.15 USD
Fair value404.34
Ethical score10.0/100
Value readUndervaluedas of 19 Nov 2026
Our investment reviews on this name
2026-11-10Read Markup336.98-10.0% to today Accumulation gives way to Markup after a 20% rise in 2 weeks
2026-10-26Read Accumulation280.01+8.3% to today ✓Markup gives way to Accumulation after a 15% rise in 3 weeks
2026-10-02Read Markup242.70+24.9% to today ✓Markdown gives way to Markup after a 16% slide in 5 weeks
2026-08-29Read Markdown287.62+5.4% to today Distribution gives way to Markdown with volume flow in agreement

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Royal Caribbean Group holds its Markup at $303.15. Consolidating, no directional conviction, held for 1 days.

As held on the ledger · 2026-11-19
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 1 days
Price at the screen$303.15
Valuation20.11 trailing · 16.59 forward price to earnings
Values screenFAIL · score 10.0
Beta1.86
The Workings

Five Screens: RCL's Results

FAIL. Debt ratio

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 52.94% Below 33% Fail
Interest-bearing cash 0.00% Below 33% Pass
Receivables 2.74% Below 49% Pass
Revenue purity 0.13% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Falls Short, in Plain English

Royal Caribbean's business is in a permissible area, but its interest-bearing debt is about 53% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when RCL's ethical verdict changes

Today RCL does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 25% discount to our $404.34 fair value, strong competitive moat, 8.80% revenue growth.

Model construction and limits: fair-value methodology.

338.01Conservative404.34Base case563.36Growth case 303.15Price

Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 25.0% discount to the base estimate.

The Street's Range
270.00Street low 358.00Street average 425.00Street high 303.15Price

Third-party analyst targets: 27 covering, consensus Buy. The average target sits +18% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $404.34, with a range of $338.01 to $563.36, dated to the 2026-11-19 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E16.6xpriced for continued growth
Trailing P/E20.1xa premium valuation
EPS, trailing16.90
EPS, forward20.49
Revenue growth+8.8%steady growth
Profit margin23.8%healthy profit margins
Return on equity41.3%an exceptional return on shareholder capital
FCF yield-0.06%
Dividend yield1.87%
Debt to equity1.94a meaningful debt load worth watching
Current ratio0.22below 1: short-term bills exceed liquid assets
Beta1.86much more volatile than the market
Short interest, float0.07%
52-week range222.22 - 356.39
MoatSTRONG
Market cap$90.9B
Employees107,950

RCL-specific watchpoints · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-17 Markup $323.27 -4.1% Entry 25

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (27 analysts) rates it buy, with a mean price target of $358.

2026-11-10 Markup · changed $336.98 +9.7% Entry 24

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 9.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (26 analysts) rates it buy, with a mean price target of $354.

2026-11-03 Accumulation $307.18 +9.7% Entry 23

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (26 analysts) rates it strong buy, with a mean price target of $353.

2026-10-27 Accumulation $280.01 +0.0% Entry 22

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (27 analysts) rates it buy, with a mean price target of $350. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-26 Accumulation · changed $280.01 +0.0% Entry 21

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (27 analysts) rates it buy, with a mean price target of $350. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Markup $280.01 +0.0% Entry 20

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (27 analysts) rates it buy, with a mean price target of $350. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-24 Markup $280.01 +0.0% Entry 19

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (27 analysts) rates it buy, with a mean price target of $350. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-23 Markup $280.01 +0.0% Entry 18

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (27 analysts) rates it buy, with a mean price target of $350. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-22 Markup $280.01 +0.0% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (27 analysts) rates it buy, with a mean price target of $350. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-21 Markup $280.01 +0.0% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (27 analysts) rates it buy, with a mean price target of $350. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on RCL

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in RCL's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · RCL
DateInsiderTitleTypeSharesValue
2026-11-11 Wilhelmsen Arne Alexander Dir S - Sale 185,000 $62,109,253
2026-11-06 Wilhelmsen Arne Alexander Dir S - Sale 476,674 $159,824,006
2026-11-04 Wilhelmsen Arne Alexander Dir S - Sale 250,000 $82,140,413
2026-10-30 Montiel Maritza Gomez Dir S - Sale 400 $122,884
2026-10-28 Lake Robert Alexander SVP, CLO, Secretary S - Sale 1,000 $298,430
2026-02-27 WIERNICKI CHRISTOPHER J. Director 444 ·
2026-02-27 WILHELMSEN ARNE ALEXANDER Director 771,607 $243,570,580
2026-02-24 WILHELMSEN ARNE ALEXANDER Director 473,548 $149,441,189
2026-02-19 WILHELMSEN ARNE ALEXANDER Director 206,442 $65,426,312
2026-02-17 WILHELMSEN ARNE ALEXANDER Director 280,000 $91,172,995

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming RCL
DatePoliticianPartyTypeAmount
2026-10-13 Ro Khanna Democrat buy 1K–15K
2026-10-12 Ro Khanna Democrat buy 1K–15K
2026-10-07 Ro Khanna Democrat buy 1K–15K
2026-09-25 Ro Khanna Democrat sell 1K–15K
2026-09-25 Ro Khanna Democrat sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $281.97 +13.7% · $1,137 +13.7%
2 months $245.81 +30.5% · $1,305 +30.5%
3 months $285.92 +12.2% $1.50 $1,127 +12.7%
6 months $253.27 +26.6% $3.00 $1,278 +27.8%
1 year $246.49 +30.1% $5.50 $1,323 +32.3%
2 years $224.57 +42.8% $8.55 $1,466 +46.6%
3 years $102.03 +214.3% $8.95 $3,230 +223.0%
5 years $77.79 +312.2% $8.95 $4,237 +323.7%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever RCL does next, these words stay.

Royal Caribbean Group · RCL · Markup · $303.15
Recorded 2026-11-19 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.